학술논문

Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Document Type
Article
Source
In: Blood. (Blood, 17 February 2022, 139(7):1026-1038)
Subject
Language
English
ISSN
15280020
00064971